
In first open-label phase 3 data from the ADEPT program, KarXT cut hallucination and delusion scores in Alzheimer disease psychosis, with no new safety signals.
Telemedicine is an attractive new care model–the growth potential is great, it’s easy to adopt, and so far patients are very happy with it. Telemedicine is proving to be an ideal format for improving patient engagement and is creating a greater demand for services. That’s strong incentive for private practices to embrace this new frontier of healthcare.
AdvancedMD
URL:
Phone: (800) 825-0224




